STOCK TITAN
  1. Home
  2. Sec-filings
  3. CMND
  4. [EFFECT] Clearmind Medicine Inc. SEC Filing

[EFFECT] Clearmind Medicine Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 18, 2025
Accession Number: 0001213900-25-053898
Submission Type: POS AM
CIK: 0001892500
Company Name: Clearmind Medicine Inc.
File Number: 333-276913

Source: View Original Filing on SEC EDGAR

Stock CMND logo
Clearmind Medici

NASDAQ:CMND

CMND Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

CMND Latest News

Jun 27, 2025
Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market
Jun 25, 2025
Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
Jun 24, 2025
Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics
Jun 23, 2025
Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder
Jun 12, 2025
Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

CMND Latest SEC Filings

Jun 27, 2025
[6-K] Clearmind Medicine Inc. Current Report (Foreign Issuer)
Jun 23, 2025
[6-K] Clearmind Medicine Inc. Current Report (Foreign Issuer)

CMND Stock Data

4.79M
5.20M
3.44%
13.98%
5.45%
Biotechnology
Healthcare
Link
Canada
Vancouver